Content about Histamine antagonist

April 3, 2013

The Food and Drug Administration has approved a new drug for allergies in children made by Tris Pharma, the drug maker said.

MONMOUTH JUNCTION, N.J. — The Food and Drug Administration has approved a new drug for allergies in children made by Tris Pharma, the drug maker said Wednesday.

Tris announced the approval of Karbinal ER (carbinoxamine maleate) extended-release oral suspension in the 4 mg-per-five milliliter strength. The company said the drug was the first sustained-release histamine receptor blocking agent for seasonal and perennial allergic rhinitis in children 2 and older.

August 18, 2011

Sato Pharmaceutical on Wednesday launched Zentrip, a new motion-sickness product featuring a fast-dissolving, fast-acting, citrus-flavored meclizine hydrochloride thin-strip.

TORRANCE, Calif. — Sato Pharmaceutical on Wednesday launched Zentrip, a new motion-sickness product featuring a fast-dissolving, fast-acting, citrus-flavored meclizine hydrochloride thin-strip.